9,634 Shares in CVS Health Co. (NYSE:CVS) Purchased by Unified Investment Management

Unified Investment Management purchased a new stake in shares of CVS Health Co. (NYSE:CVS - Free Report) during the 4th quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor purchased 9,634 shares of the pharmacy operator's stock, valued at approximately $432,000.

Other institutional investors have also recently made changes to their positions in the company. MidAtlantic Capital Management Inc. bought a new stake in shares of CVS Health during the 3rd quarter worth approximately $25,000. Ridgewood Investments LLC increased its holdings in shares of CVS Health by 255.7% in the 4th quarter. Ridgewood Investments LLC now owns 626 shares of the pharmacy operator's stock valued at $28,000 after acquiring an additional 450 shares during the period. Stonebridge Financial Group LLC bought a new position in CVS Health in the fourth quarter worth about $28,000. Legacy Investment Solutions LLC bought a new position in shares of CVS Health during the 3rd quarter worth approximately $31,000. Finally, Financial Perspectives Inc lifted its holdings in shares of CVS Health by 137.5% during the 4th quarter. Financial Perspectives Inc now owns 805 shares of the pharmacy operator's stock valued at $36,000 after purchasing an additional 466 shares during the last quarter. Institutional investors own 80.66% of the company's stock.

Insider Buying and Selling

In other CVS Health news, Director Michael F. Mahoney bought 30,000 shares of the firm's stock in a transaction on Tuesday, February 18th. The shares were acquired at an average cost of $66.70 per share, with a total value of $2,001,000.00. Following the purchase, the director now directly owns 39,356 shares of the company's stock, valued at $2,625,045.20. This trade represents a 320.65 % increase in their position. The acquisition was disclosed in a filing with the SEC, which is available through this hyperlink. 0.24% of the stock is currently owned by company insiders.

Analysts Set New Price Targets

Several equities analysts recently commented on CVS shares. Evercore ISI increased their price objective on shares of CVS Health from $60.00 to $65.00 and gave the company an "outperform" rating in a research report on Monday, January 27th. Deutsche Bank Aktiengesellschaft raised shares of CVS Health from a "hold" rating to a "buy" rating and set a $66.00 price target on the stock in a report on Tuesday, December 3rd. Leerink Partners raised CVS Health from a "market perform" rating to an "outperform" rating and boosted their price objective for the company from $55.00 to $75.00 in a report on Thursday, February 13th. Royal Bank of Canada dropped their target price on CVS Health from $68.00 to $58.00 and set an "outperform" rating on the stock in a report on Friday, November 15th. Finally, StockNews.com raised CVS Health from a "sell" rating to a "hold" rating in a report on Thursday, February 13th. Four investment analysts have rated the stock with a hold rating, seventeen have issued a buy rating and one has given a strong buy rating to the stock. According to MarketBeat, the stock currently has an average rating of "Moderate Buy" and an average price target of $69.83.

CVS Health Price Performance

NYSE:CVS traded down $0.90 during trading hours on Monday, hitting $64.82. 7,077,932 shares of the stock were exchanged, compared to its average volume of 12,413,927. The firm's fifty day moving average price is $54.74 and its 200 day moving average price is $56.53. CVS Health Co. has a 52-week low of $43.56 and a 52-week high of $80.75. The company has a market cap of $81.72 billion, a P/E ratio of 17.71, a P/E/G ratio of 0.98 and a beta of 0.61. The company has a current ratio of 0.81, a quick ratio of 0.60 and a debt-to-equity ratio of 0.80.

CVS Health (NYSE:CVS - Get Free Report) last issued its quarterly earnings results on Wednesday, February 12th. The pharmacy operator reported $1.19 EPS for the quarter, topping the consensus estimate of $0.89 by $0.30. CVS Health had a return on equity of 9.11% and a net margin of 1.24%. As a group, equities research analysts anticipate that CVS Health Co. will post 5.89 EPS for the current fiscal year.

CVS Health Dividend Announcement

The firm also recently declared a quarterly dividend, which was paid on Monday, February 3rd. Stockholders of record on Thursday, January 23rd were paid a $0.665 dividend. This represents a $2.66 annualized dividend and a dividend yield of 4.10%. The ex-dividend date was Thursday, January 23rd. CVS Health's dividend payout ratio is currently 72.68%.

About CVS Health

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.